Retraction
Amino Acid-Responsive Crohn’s Disease: A Case Study
Paper Information
Record ID:
24815
Author(s):
Publication Date:
December 06, 2010
Retraction Date:
December 16, 2020
(4.9 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (22)
22
Total Citations0
Post-Retraction22
Pre-Retraction0
Same DayMechanisms of Regulation of Transporters of Amino Acid Absorption in Inflammatory Bowel Diseases
Soudamani Singh, Subha Arthur, Uma Sundaram
Comprehensive physiology
Published: Apr 2020
259 days before retraction
Mechanisms of Regulation of Transporters of Amino Acid Absorption in Inflammatory Bowel Diseases
Soudamani Singh, Subha Arthur, Uma Sundaram
Comprehensive physiology
Published: Mar 2020
9 citations
9 citations
279 days before retraction
Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children
François‐Pierre Martin, Mingming Su, Guoxiang Xie et al. (8 authors)
World Journal of Gastroenterology
Open Access
Published: Jan 2017
50 citations
50 citations
1445 days before retraction
Parkinson’s disease managing reversible neurodegeneration
Marty Hinz, Alvin Stein, Ted Cole et al. (5 authors)
Neuropsychiatric Disease and Treatment
Open Access
Published: Apr 2016
3 citations
3 citations
1720 days before retraction
Identification of OCTN2 variants and their association with phenotypes of Crohn’s disease in a Korean population
Hyojin Park, Eun Suk Jung, Kyoung Ae Kong et al. (6 authors)
Scientific Reports
Open Access
Published: Mar 2016
16 citations
16 citations
1741 days before retraction
Parkinson’s disease-associated melanin steal
Marty Hinz, Alvin Stein, Ted Cole
Neuropsychiatric Disease and Treatment
Open Access
Published: Dec 2014
4 citations
4 citations
2207 days before retraction
Parkinson's disease: carbidopa, nausea, and dyskinesia
Marty Hinz, Alvin Stein, Ted Cole
Clinical Pharmacology Advances and Applications
Open Access
Published: Nov 2014
12 citations
12 citations
2237 days before retraction
The Parkinson's disease death rate: carbidopa and vitamin B6
Marty Hinz, Alvin Stein, Ted Cole
Clinical Pharmacology Advances and Applications
Open Access
Published: Oct 2014
20 citations
20 citations
2268 days before retraction
Management of L-dopa overdose in the competitive inhibition state
Marty Hinz, Alvin Stein, Ted Cole
Drug Healthcare and Patient Safety
Open Access
Published: Jul 2014
4 citations
4 citations
2360 days before retraction
Administration of supplemental L-tyrosine with phenelzine: a clinical literature review
Marty Hinz, Alvin Stein, Ted Cole et al. (4 authors)
Clinical Pharmacology Advances and Applications
Open Access
Published: Jul 2014
2360 days before retraction
5-HTP efficacy and contraindications
Marty Hinz, Alvin Stein, Marty Hinz
Neuropsychiatric Disease and Treatment
Open Access
Published: Jul 2012
29 citations
29 citations
3090 days before retraction
Relative nutritional deficiencies associated with centrally acting monoamines
Marty Hinz, Alvin Stein, Thomas Uncini
International Journal of General Medicine
Open Access
Published: May 2012
11 citations
11 citations
3151 days before retraction
The discrediting of the monoamine hypothesis
Marty Hinz, Alvin Stein, Thomas Uncini
International Journal of General Medicine
Open Access
Published: Feb 2012
19 citations
19 citations
3241 days before retraction
Monoamine depletion by reuptake inhibitors
Marty Hinz, Alvin Stein, Thomas Uncini
Drug Healthcare and Patient Safety
Open Access
Published: Oct 2011
11 citations
11 citations
3364 days before retraction
APRESS: apical regulatory super system, serotonin, and dopamine interaction
Marty Hinz, Alvin Stein, Thomas Uncini
Neuropsychiatric Disease and Treatment
Open Access
Published: Aug 2011
14 citations
14 citations
3425 days before retraction
Paper citing Validity of Urinary Monoamine Assay Sales Under th...
Unknown Authors
Unknown Journal
Published: Aug 2011
3425 days before retraction
Validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter testing marketing model”
Marty Hinz, Alvin Stein, Thomas Uncini
International Journal of Nephrology and Renovascular Disease
Open Access
Published: Jul 2011
11 citations
11 citations
3456 days before retraction
Paper citing The Dual-Gate Lumen Model of Renal Monoamine Trans...
Unknown Authors
Unknown Journal
Published: Feb 2011
3606 days before retraction
Amino acid management of Parkinson’s disease: a case study
Marty Hinz, Alvin Stein, Thomas Uncini
International Journal of General Medicine
Open Access
Published: Feb 2011
27 citations
27 citations
3606 days before retraction
Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine
Marty Hinz, Alvin Stein, Thomas Uncini
Open Access Journal of Urology
Open Access
Published: Feb 2011
16 citations
16 citations
3606 days before retraction
Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation
Marty Hinz, Alvin Stein, Robert A. Neff et al. (5 authors)
Neuropsychiatric Disease and Treatment
Open Access
Published: Jan 2011
20 citations
20 citations
3637 days before retraction
Neurotransmitters excreted in the urine as biomarkers of nervous system activity: Validity and clinical applicability
David T. Marc, Joseph W. Ailts, Danielle Ailts Campeau et al. (5 authors)
Neuroscience & Biobehavioral Reviews
Published: Aug 2010
148 citations
148 citations
3783 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #23206
Apr 23, 2020Quick Stats
Total Citations:
22
Years Since Retraction:
4.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025